DNA Vaccines Market represent a holistic view as a protection against infectious disease and may enhance human and animal welfare, minimize antibiotic usage and also curtail the proliferation of pathogens. Injectable and edible DNA vaccines exhibit a determined approach for rapid immunization against several diseases that are problematic to eliminate traditional vaccines and antibiotics. Other potential uses of DNA vaccines are inclusive of autoimmune disease, allergies, and treatment of cancer. On the basis of geographic segmentation, the global DNA vaccines market spans North America, Latin America, Asia-Pacific, Middle-East, and Africa.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/dna-vaccines-market/request-sample
The key driving factors responsible for the growth of DNA Vaccines
market :
Other potent uses of DNA vaccines
include low cost, ease of production and enhanced quality on heat stability,
identical production processes for different vaccines. A DNA vaccine comprises
a bacterial plasmid that induces the immune system. When a patient is
administered with the DNA vaccine, the mechanism in their cells make a viral or
bacterial protein in which their immune system considers as alien to the body.
DNA vaccines are different to conventional vaccines are made up of bacteria or
viruses or a part of bacteria or virus such as protein.
Advantages in using the DNA
vaccines can be summed as such vaccines need short time span, easy to transport
and service, are very cheap to make, and there is no risk to those who are
involved in making the vaccine. Disadvantages include initial attempts to
create DNA vaccines are less significant on consumption by human body and most
of the DNA vaccines are not open for human use yet. Therefore, considering the pros
and cons coupled with market dynamics, the global market for DNA vaccines
witnesses a higher CAGR growth during the forecast period.
The key driving factors
responsible for the growth of DNA vaccines market include growing vulnerability
of population to infectious disease and rising number of antibiotics resistant
pathogens have generated the need for effective and low cost vaccination which
would provide lasting immunity. On the basis of disease type, the global DNA
vaccines market is segmented into human DNA vaccines and animal DNA vaccines.
Human DNA vaccines market is further segmented into HIV infection, cancer and
infectious diseases.
On the basis of technology, the
global DNA vaccines market is segmented into pDNA vaccines technology and pDNA
delivery technology. pDNA vaccines technology is further sub-segmented into
therapeutic technology and preventive technology. pDNA delivery technology is
further sub-segmented into uncomplexed pDNA, liposomes, gold particles,
electroporation, bacteriophages, bacterial ghosts, nanoparticles and viruses.
On the basis of application, the
global DNA vaccines market is segmented into human diseases, and veterinary
diseases. Human diseases are further sub-segmented into oncology, allergies and
infectious diseases. Oncology is further sub-segmented into pancreatic cancer,
breast cancer, ovarian cancer, small cell lung cancer and melanoma. Infectious
disease is further segmented into CMV, HBV, HCV, HIV and Influenza.
Veterinary disease is further
sub-segmented into canine melanoma, leishmaniosis, and Equine West NileVirus.
The key players in the global DNA vaccines market spans Novartis Animal Health,
Inovio Biomedical Corp, Merck & Co, Dendreon Corporation, Pfizer pharmaceuticals,
GlaxoSmithKline, Advance Bioscience Laboratories Inc, Indian Immunologicals
Ltd, Xenetic Biosciences Inc, QED Biosciences Inc, Astellas Pharma, Vical,
Sanofi and Tekmira Pharmaceuticals.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/dna-vaccines-market
No comments:
Post a Comment